Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
about
Rituximab for troublesome cases of childhood nephrotic syndrome.The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysisSingle dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease.Rituximab in idiopathic nephrotic syndrome: does it make sense?Is rituximab effective in childhood nephrotic syndrome? Yes and no.Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome.T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.Minimal Change Disease.Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndrome.
P2860
Q34683518-30DC7C0D-8F7F-4E22-897D-79FD4062E541Q35040896-0CF5E7B7-4817-4B50-9FD3-E976F7E17766Q37108328-DA72B179-44C1-4EB4-B77B-337B87EAE087Q37261621-96731F6C-1836-420E-9F35-5A96A1CBA547Q37375752-911AE8DE-327E-4C28-9B7D-2EA1F1B7CADEQ38118894-FDCDACD8-3E88-4EF6-97BA-968DF40B425BQ38569641-2BE5E162-9948-4406-93E6-0FA8BF796E4FQ38679589-8B4D68A4-02E3-43C4-ABFC-1D0A749AFAD8Q38701126-CD630D40-1B9B-4512-8B85-33B75D213A4CQ38895019-7E78AC68-6585-4359-BA6F-CBBF7521286FQ39456170-D55002DF-FDEE-477B-906C-D6D7B254487AQ39573394-0D0D397A-3021-4C02-923F-74B2238790D2Q40572300-7A2F0341-0064-40FB-AD70-39A250B7828EQ41387077-4E8278F0-E014-46FB-B9A1-5677ECB2B95AQ42083009-18188386-7DF7-4159-AE19-147866ED8A46Q43506114-BCBD745D-2810-44AD-99E2-B41E5BDCAEFDQ52945061-2B1C8DA0-6CEA-4FF9-8B21-E7C028D8CA59Q53838634-7AB97352-8C0B-4985-98FC-9782782A3845Q54588259-2B8B3E0D-85E2-4F5F-AA32-0D8C5E4C841C
P2860
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@en
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@nl
type
label
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@en
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@nl
prefLabel
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@en
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@nl
P2093
P2860
P1433
P1476
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
@en
P2093
Arnaud Garnier
Aurélia Bertholet-Thomas
Brigitte Llanas
Christine Pietrement
Flavio Bandin
Karine Brochard
Lydia Ichay
Mathilde Cailliez
Olivier Dunand
Stéphane Decramer
P2860
P2888
P304
P356
10.1007/S00467-012-2406-3
P577
2013-01-23T00:00:00Z
P6179
1011349484